Drug Type Small molecule drug |
Synonyms Picillibacta, ピシリバクタ, 威奇达 |
Target |
Mechanism β-lactamase inhibitors(Beta Lactamase inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 2001), |
Regulation- |
Molecular FormulaC8H11NNaO5S |
InChIKeySXKMQCSYTIDQTC-IBTYICNHSA-N |
CAS Registry69388-84-7 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Cystitis | JP | 09 Mar 2005 | |
Lung Abscess | JP | 09 Mar 2005 | |
Peritonitis | JP | 09 Mar 2005 | |
Pneumonia | JP | 09 Mar 2005 | |
Bacterial Infections | CN | 01 Jan 2001 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Abdominal sepsis | Phase 2 | CN | - | 17 Oct 2013 |
Abscess of oral tissue | Phase 2 | CN | - | 17 Oct 2013 |
Gynecological infection | Phase 2 | CN | - | 17 Oct 2013 |
Laryngitis | Phase 2 | CN | - | 17 Oct 2013 |
Osteomyelitis | Phase 2 | CN | - | 17 Oct 2013 |
Paratyphoid Fever | Phase 2 | CN | - | 17 Oct 2013 |
Pyelonephritis | Phase 2 | CN | - | 17 Oct 2013 |
Skin structures and soft tissue infections | Phase 2 | CN | - | 17 Oct 2013 |
Tonsillitis | Phase 2 | CN | - | 17 Oct 2013 |
Typhoid Fever | Phase 2 | CN | - | 17 Oct 2013 |